-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Building a Nationwide Sickle Cell Disease Data Hub and Learning Community

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases
Monday, December 12, 2022: 2:45 PM-4:15 PM
217-219 (Ernest N. Morial Convention Center)
Chair:
Alexis A. Thompson, MD, MPH, Northwestern University
Disclosures:
Thompson: Global Blood Therapeutic: Current equity holder in publicly-traded company, Membership on an entity's Board of Directors or advisory committees; Beam: Consultancy; CRISPR/Vertex: Consultancy, Research Funding; Editas: Research Funding; bluebird bio, Inc.: Consultancy, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; Novartis: Research Funding; Baxalta: Research Funding; Biomarin: Research Funding; Agios: Consultancy.

Alexis A. Thompson, MD, MPH

Northwestern University, Chicago, IL

Alexis A. Thompson, MD, MPH

Northwestern University, Chicago, IL

Alexis A. Thompson, MD, MPH

Northwestern University, Chicago, IL

Carole Lannon

Cincinnati Children's, Cincinnati, OH

Amanda M. Brandow, DO, MS

Medical College of Wisconsin, Milwaukee, WI

Venee N. Tubman, MD

Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX

Alexis A. Thompson, MD, MPH

Northwestern University, Chicago, IL

Alexis A. Thompson, MD, MPH

Northwestern University, Chicago, IL